SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-027920
Filing Date
2024-03-07
Accepted
2024-03-07 16:05:33
Documents
90
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K svra-20231231.htm   iXBRL 10-K 2277001
2 EX-10.36 svra-ex10_36.htm EX-10.36 99811
3 EX-23.1 svra-ex23_1.htm EX-23.1 3332
4 EX-31.1 svra-ex31_1.htm EX-31.1 13587
5 EX-31.2 svra-ex31_2.htm EX-31.2 13665
6 EX-32.1 svra-ex32_1.htm EX-32.1 11757
7 EX-97 svra-ex97.htm EX-97 28979
8 GRAPHIC img198116697_0.jpg GRAPHIC 5538
9 GRAPHIC img198116697_1.jpg GRAPHIC 32100
10 GRAPHIC img198116697_2.jpg GRAPHIC 35450
  Complete submission text file 0000950170-24-027920.txt   10426599

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT svra-20231231.xsd EX-101.SCH 1562431
92 EXTRACTED XBRL INSTANCE DOCUMENT svra-20231231_htm.xml XML 1727374
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32157 | Film No.: 24730043
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)